Kilter Group’s Sabra Healthcare REIT SBRA Stock Holding History

Kilter Group’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-55	Closed	-$1.06K	–	1695
2026 Q1	$1.06K	Buy	+55	New	+$1.08K	﹤0.01%	1216

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kilter Group's SBRA Position: Q2 2026 in Review

Kilter Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 55 shares — an estimated $1.06K sold.

Kilter Group first reported a position in SBRA in Q1 2026 and held it in 1 quarter. The position peaked at $1.06K in Q1 2026. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Kilter Group reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
Kilter Group sold 55 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.06K.
Kilter Group first reported a position in Sabra Healthcare REIT in Q1 2026 and held it in 1 quarter.
Kilter Group's Sabra Healthcare REIT position peaked at $1.06K in Q1 2026.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.